Ronald Przygodzki, MD, Acting Director of BLRD
Ronald M. Przygodzki, M.D. holds a degree in medicine from the Medical University of Warsaw, Poland. He is board certified in anatomic and clinical pathology (American Board of Pathology), with subspecialization in molecular genetic pathology (American Board of Pathology and American Board of Medical Genetics). He has over 25 years of research and clinical experience with over 15 years of administrative experience. He is serving the position of Acting Director of the Biomedical Laboratory Research & Development (BLRD). Concurrently, he is the Associate Director of the Genomic Medicine Program, and oversees genomic-based research including the Million Veteran Program. His previous leadership roles (private and public sectors) include being Chief of Pathology at the Children's National Medical Center and as Associate Director of the Molecular Diagnostics Laboratory at the Armed Forces Institute of Pathology, both in Washington DC.
Dr. Przygodzki's research expertise and interests are in anatomic and clinical pathology and molecular genomics, spanning from the theoretical to practical clinically translatable arenas. This includes anatomic and clinical pathology (laboratory medicine), pediatric pathology, molecular genetics, pharmacogenomics, toxicogenomics, epigenomics, mitochondrial disease genomics, surgical pathology, blood banking, biobanking, and the cellular basis of disease (pathobiology). He has mentored over 50 residents and fellows. He has developed unique molecular-based techniques—in particular, ones invented around the use of small archival tissue specimens typically found in pathology. Dr. Przygodzki has authored several publications as well as book chapters. Some of his molecular pathology research efforts led to the reclassification of two pulmonary malignancies by the World Health Organization, and have allowed him to receive national and international recognition.
Dr. Przygodzki believes that as a continuously self-renewing enterprise, BLRD's organizational structure, operating procedures, and programs are designed to enable the organization to achieve its goals, deliver quality, and enhance performance to improve results. Among the efforts, are (1) to attract, train, retain, and nurture the highest quality investigators and staff as leaders in their field and VHA; (2) to manage and improve BLRD operations to ensure quality, promote standardization, increase effectiveness, and ensure the efficiency of integrated support and the alignment of resources to the strategic plan; and (3) to communicate the value of BLRD research as it relates to developing science, and building trusted intra- and extramural partnerships that improve Veteran well-being. Among the large-scale efforts are the growth and establishment of the Million Veteran Program with the aim of becoming a resource for investigators requiring large-scale analyses using genomic, phenotypic and survey/medical record data for inquiry and discovery. A second effort is standardizing BLRD review operations with the ultimate aim of becoming ISO9001 certified.